Abstract | BACKGROUND: GOALS: To determine APRI/FIB-4 accuracy for predicting histologic liver fibrosis and evaluate whether incorporating change in index improves test accuracy in hepatitis C virus (HCV)-infected Alaska Native persons. STUDY: Using liver histology as the gold standard, we determined the test characteristics of APRI to predict Metavir ≥F2 fibrosis and FIB-4 to predict Metavir ≥F3 fibrosis. Index discrimination was measured as the area under the receiver operator characteristic curve. We fit a logistic regression model to determine whether incorporating change in APRI/FIB-4 over time improved index discrimination. RESULTS: Among 283 participants, 46% were female, 48% had a body mass index >30, 11% had diabetes mellitus, 8% reported current heavy alcohol use. Participants were infected with HCV genotypes 1 (68%), 2 (17%), or 3 (15%). On liver histology, 30% of study participants had ≥F2 fibrosis and 15% had ≥F3 fibrosis. The positive predictive value of an APRI>1.5/FIB-4>3.25 for identifying fibrosis was 77%/78%. The negative predictive value of an APRI<0.5/FIB-4<1.45 was 91%/87%. The area under the receiver operator characteristic curve of an APRI/FIB-4 for identifying fibrosis was 0.82/0.84. Incorporating change in APRI/FIB-4 did not improve index discrimination. CONCLUSIONS: The accuracy of APRI/FIB-4 for identifying liver fibrosis in HCV-infected Alaska Native persons is similar to that reported in other populations and could help prioritize patients for treatment living in areas without access to liver biopsy. Change in APRI/FIB-4 was not predictive of degree of fibrosis.
|
Authors | Prabhu P Gounder, Celia Haering, Dana J T Bruden, Lisa Townshend-Bulson, Brenna C Simons, Philip R Spradling, Brian J McMahon |
Journal | Journal of clinical gastroenterology
(J Clin Gastroenterol)
Vol. 52
Issue 1
Pg. 60-66
(Jan 2018)
ISSN: 1539-2031 [Electronic] United States |
PMID | 27875352
(Publication Type: Journal Article, Observational Study)
|
Chemical References |
- Aspartate Aminotransferases
|
Topics |
- Alaska
- Aspartate Aminotransferases
(blood)
- Cohort Studies
- Female
- Hepatitis C, Chronic
- Humans
- Liver Cirrhosis
(blood, diagnosis, physiopathology)
- Longitudinal Studies
- Male
- Middle Aged
- Platelet Count
- Predictive Value of Tests
- Severity of Illness Index
|